HYPERTENSION DIAGNOSTICS HDII overview

TORONTO, ON / ACCESSWIRE / June 17, 2020 / Hypertention Diagnostics, Inc.(OTCMKTS:HDII) ("Hypertension Diagnostics" or the "Company") CEO Liangjian Peng said he received a lot of inquiries about the Company future development. Mr. Peng thanks all inquired people, and he said the company is working on to remove the STOP sign as soon as possible, and switch to Current Pink before implementing any M&A issues. About Hypertension Diagnostics Inc. Hypertension Diagnostics, Inc. is a public company...

TORONTO, ON / ACCESSWIRE / June 8, 2020 / Hypertention Diagnostics Inc.(OTCMKTS:HDII) ("Hypertension Diagnostics" or the "Company") is pleased to announce that the Company's internal control dispute has been resolved, leaving Liangjian Peng in control as the CEO and controlling shareholder of Hypertension Diagnostics. The Company is currently pursuing an M&A-driven strategy, with advanced discussions now underway. Due to the COVID-19 global health crisis, Mr. Peng has been unable to travel to...

...

TORONTO, ON / ACCESSWIRE / February 20, 2020 / Mr. Peng Liangjian, CEO of Hypertension Diagnostics Inc. (OTC PINK:HDII), had a meeting with Mr. Zheng Ding, the chairman of Shanghai CinTel Intelligent Ltd. (CinTel) on February 14, 2020. Mr. Peng introduced Hypertension Diagnostics Inc (HDII) and US Stock Markets to Cintel. Mr. Ding is interested in North American capital markets, and the two discussed the possibilities of bringing the China based company to the U.S. stock markets. About Shanghai...

TORONTO, ON / ACCESSWIRE / February 14, 2020 / The Company HDII (OTC PINK:HDII) Hypertension Diagnostics Inc. would like to inform the Shareholders at this time that: the Company is fully confident of taking Legal Action against Mr. Brimmer in regard to his unlawful claims. Mr. Liangjian Peng, the current CEO of Hypertension Diagnostics Inc. states that "I will continue looking for the best merge target. I believe that HDII will make great strides in 2020, the year of rat . We will always...

TORONTO, ON / ACCESSWIRE / February 11, 2020 / The Company HDII (OTC PINK:HDII), at this time would like to inform all Shareholders that the Company, Gerpang Healthcare Group, located in Jinan Pharma Valley will not be Merging into Hypertension Diagnostics Inc., at this time. Gerpang Healthcare Inc. has decided to enter into an Agreement with a different Company due to the recent Control Dispute caused by previous Management, Kenneth Brimmer. Liangjian Peng the current CEO, was able to bring the...

TORONTO, ON / ACCESSWIRE / October 2, 2019 / There appears to be a control dispute for Hypertension Diagnostics, Inc. (OTC PINK:HDII) involving Mr. Liangjian Peng and another party. HDII's attorney Stephen Mills is currently dealing with the dispute. We believe this matter will be solved very soon. Mr. Peng, CEO of HDII affirms that he is sole officer and only preferred shares holder of HDII. Mr. Peng will travel to China on October 4, 2019, he will visit ShanDong GerPang Healthcare Group to...